The global leukemia market was worth $XX million in 2018 and is forecasted to reach $XX million by 2026, at a CAGR of XX% during the forecast period.
Leukemia is a type of cancer that affects the blood and bone marrow. It originates in the bone marrow and results in the abnormality in leucocytes or white blood cells. White blood cells help body fight infection, and they are formed in the bone marrow. In leukemia, the bone marrow starts producing abnormal white blood cells. These cells crowd out the healthy blood cells, making it hard for blood to do its work. The major types of leukemias include acute lymphocytic leukemia (ALL), chronic lymphocytic leukemia (CLL), acute myeloid leukemia (AML), and chronic myeloid leukemia (CML). Prevalence of leukemia is quite high globally. According to the American Cancer Society (ACS), there will be around 62,000 estimated cases of Leukemia in 2019 in U.S. Leukemia begins in a cell in the bone marrow and changes the cell to become a type of leukemia cell. After the leukemic change, the leukemia cells may grow and survive better than normal cells. With time, the leukemia cells crowd out or suppress the development of normal cells. The rate of replacement of normal blood and marrow cells and at which leukemia progress are different with each type of leukemia. Leukemia occurs most often in adults older over the age of 55, but it is also the most common cancer in children younger than 15.
The market is driven by a rise in prevalence population, robust pipeline, rise in healthcare expenditure, and technological advancements.
Childhood leukemia is the most common type of cancer in children and teens. The incidence rate of Leukemia is highest in children, among other cancers.
High costs associated with drug development and adverse side-effects related to chemotherapeutic options are going to restrain the market in the forecast period.
The global leukemia market can be segmented by disease type as Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia, and Chronic Myeloid Leukemia and by treatment type as Medication, Surgery, Chemotherapy, Biological Therapy, Immunotherapy, Radiation Therapy, Targeted Therapy, and Stem Cell Transplantation.
Acute Lymphocytic Leukemia is the most common type of Leukemia among children. According to ACS, around 3 out of 4, childhood leukemias are Acute Lymphocytic Leukemia. This leukemia starts in early forms of white blood cells called lymphocytes. Over the period of forecast incidence cases of Acute Lymphocytic Leukemia are expected to grow, leading to growth in their therapeutics market. This cancer usually gets worse quickly if it is not treated. In a child with this type of cancer, too many stem cells become lymphoblasts, B lymphocytes, or T lymphocytes. The cells do not work like normal lymphocytes and are not able to fight infection very well. These cells are cancer cells. Also, as the number of leukemia cells increases in the blood and bone marrow, there is less room for healthy white blood cells, red blood cells, and platelets. This leads to infection, anemia, and easy bleeding.
Chemotherapy is the use of anti-cancer drugs that are injected into the vein, under the skin, or into the cerebrospinal fluid. When given into the cerebrospinal fluid, these drugs enter the bloodstream and reach all areas of the body, making this treatment useful for leukemia that spread throughout the body. Chemotherapy is the main treatment for most people with leukemia. Chemotherapy uses potent drugs or chemicals, often in combinations or intervals, to kill or damage cancer cells in the body.
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
